查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1876528

经皮肾镜取石术市场机会、成长驱动因素、产业趋势分析及预测（2025-2034年）

Percutaneous Nephrolithotomy Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 140 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年全球经皮肾镜取石术市场价值为 12 亿美元，预计到 2034 年将以 6.8% 的复合年增长率增长至 23 亿美元。

经皮肾镜取石术市场 - IMG1

肾结石市场扩张的驱动因素包括：肾结石发病率的上升、患者对微创手术的偏好日益增长、经皮肾镜取石术（PCNL）器械技术的快速发展，以及随着专科医疗服务可及性的提高而不断增长的医疗保健支出。微创PCNL手术正逐渐成为治疗大型或复杂肾结石的首选方案，尤其适用于无法透过非侵入性或微创技术处理的病例。此手术只需在肾臟上做一个小切口，即可使用肾镜直接进入肾臟，从而实现精准的结石碎裂和取出，最大限度地减少组织损伤，并缩短恢復时间。发展中国家外科基础设施的扩建以及政府为改善泌尿外科医疗服务所采取的倡议，进一步推动了手术量的增长，并使更多患者能够获得先进的PCNL治疗方案。

市场范围
起始年份 2024
预测年份 2025-2034
起始值 12亿美元
预测值 23亿美元
复合年增长率 6.8%

由于肾镜在经皮肾镜取石术（PCNL）中发挥着不可或缺的作用，预计到2024年，肾镜市场份额将达到37.8%。微型化和数位化肾镜的日益普及，以及不断提升视觉化效果和手术精准度的产品创新，巩固了该领域的领先地位。受肥胖、脱水和高钠饮食等生活方式因素的影响，泌尿系结石的发生率不断上升，导致需要进行PCNL手术的患者数量增加，从而直接推动了对高性能肾镜的需求。

2024年，标准经皮肾镜取石术（PCNL）市场规模达到6.904亿美元，预计2034年将以6.7%的复合年增长率成长。由于其结石清除率优于其他治疗方案，标准PCNL仍是去除大于2公分肾结石（包括鹿角状结石）的首选技术。其已证实的临床疗效确保了该技术在已开发市场和新兴市场均持续应用。

2024年，北美经皮肾镜取石术（PCNL）市占率达39.8%。该地区是全球肾结石发病率最高的地区之一，其主要驱动因素包括肥胖、高钠摄取、久坐不动的生活方式以及富含加工食品和动物性蛋白质的饮食。这些因素导致PCNL手术需求不断增长，从而推动了市场的强劲成长。

全球经皮肾镜取石术市场的主要参与者包括 ADVIN、B. BRAUN、Becton, Dickinson and Company、Boston Scientific、Coloplast、COOK MEDICAL、Dornier MedTech、ELMED、EMS ELECTRO MEDICAL SYSTEMS、KARL STORZ、OLYMPUS、PolyDia0ost、RichardDICAL SYSTEM。经皮肾镜取石术市场的各公司正透过多种策略措施巩固其市场地位。他们大力投资研发，以提高设备的效率、小型化程度和成像能力。各公司透过建立合作伙伴关係和开展合作来扩大地域覆盖范围并实现产品多元化。策略收购使公司能够巩固市场份额并获得创新技术。专注于新兴市场能够抓住新的成长机会。重视先进的数位化和微创解决方案有助于提升竞争优势。

目录

第一章：方法论与范围

第二章：执行概要

第三章：行业洞察

  • 产业生态系分析
  • 产业影响因素
    • 成长驱动因素
      • 肾结石疾病发生率上升
      • 微创泌尿外科手术的普及率不断提高
      • PCNL仪器和雷射技术的进步
      • 微创经皮肾镜取石术（mini-PCNL）和微型经皮肾镜取石术（micro-PCNL）技术越来越受欢迎
    • 产业陷阱与挑战
      • PCNL设备和手术费用高昂
      • 手术併发症和术后感染的风险
    • 市场机会
      • 一次性经皮肾镜取石术器械的应用日益广泛
      • 新兴市场的扩张
  • 成长潜力分析
  • 监管环境
    • 北美洲
    • 欧洲
    • 亚太地区
  • 技术格局
    • 当前技术趋势
    • 新兴技术
  • 报销方案
  • 未来市场趋势
  • 价值链分析
  • 波特的分析
  • PESTEL 分析
  • 差距分析
  • 创业场景
  • 消费者行为洞察

第四章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
    • 全球的
    • 北美洲
    • 欧洲
    • 亚太地区
  • 竞争定位矩阵
  • 主要市场参与者的竞争分析
  • 关键进展
    • 併购
    • 合作伙伴关係与合作
    • 新产品发布
    • 扩张计划

第五章：市场估算与预测：依产品类型划分，2021-2034年

  • 主要趋势
  • 肾镜
    • 死板的
    • 灵活的
  • 体外碎石系统
  • 访问系统
  • 其他产品类型

第六章：市场估计与预测：依手术类型划分，2021-2034年

  • 主要趋势
  • 标准PCNL
  • 微创经皮肾镜取石术
  • 微型经皮肾镜取石术

第七章：市场估计与预测：依病患划分，2021-2034年

  • 主要趋势
  • 成人
  • 儿科

第八章：市场估算与预测：依最终用途划分，2021-2034年

  • 主要趋势
  • 医院
  • 门诊手术中心
  • 其他最终用途

第九章：市场估计与预测：依地区划分，2021-2034年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第十章：公司简介

  • ADVIN
  • B. BRAUN
  • Becton, Dickinson and Company
  • Boston Scientific
  • Coloplast
  • COOK MEDICAL
  • Dornier MedTech
  • ELMED
  • EMS ELECTRO MEDICAL SYSTEMS
  • KARL STORZ
  • OLYMPUS
  • PolyDiagnost
  • Richard Wolf
  • Teleflex
简介目录
Product Code: 15105

The Global Percutaneous Nephrolithotomy Market was valued at USD 1.2 billion in 2024 and is estimated to grow at a CAGR of 6.8% to reach USD 2.3 billion by 2034.

Percutaneous Nephrolithotomy Market - IMG1

Market expansion is driven by the increasing prevalence of kidney stones, growing patient preference for minimally invasive surgical procedures, rapid technological advancements in PCNL devices, and rising healthcare spending with improved access to specialized care. Minimally invasive PCNL procedures are becoming a preferred solution for treating large or complex kidney stones that cannot be addressed by non-invasive or less invasive techniques. The procedure involves a small incision to access the kidney directly using a nephroscope, allowing precise stone fragmentation and removal with minimal tissue damage and reduced recovery time. Expanding surgical infrastructure in developing regions and government initiatives to improve urological care further boost procedure volumes and broaden patient access to advanced PCNL treatment options.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$1.2 Billion
Forecast Value$2.3 Billion
CAGR6.8%

The nephroscopes segment captured a share of 37.8% in 2024 owing to their indispensable role in PCNL procedures. Rising adoption of miniaturized and digital nephroscopes, along with ongoing product innovations enhancing visualization and surgical precision, reinforces the segment's leadership. The growing incidence of urolithiasis, influenced by lifestyle factors such as obesity, dehydration, and high-sodium diets, increases the number of patients requiring PCNL procedures, directly driving demand for high-performance nephroscopes.

The standard PCNL segment generated USD 690.4 million in 2024 and is expected to grow at a CAGR of 6.7% through 2034. Standard PCNL continues to be the preferred technique for removing kidney stones larger than 2 cm, including staghorn stones, due to its superior stone clearance rates compared to other treatment options. Its established clinical effectiveness ensures continued adoption across both developed and emerging markets.

North America Percutaneous Nephrolithotomy Market held a 39.8% share in 2024. The region experiences one of the highest incidences of kidney stones globally, driven by factors such as obesity, high sodium intake, sedentary lifestyles, and diets rich in processed foods and animal protein. These factors contribute to increasing demand for PCNL procedures, supporting strong market growth.

Key players in the Global Percutaneous Nephrolithotomy Market include ADVIN, B. BRAUN, Becton, Dickinson and Company, Boston Scientific, Coloplast, COOK MEDICAL, Dornier MedTech, ELMED, EMS ELECTRO MEDICAL SYSTEMS, KARL STORZ, OLYMPUS, PolyDiagnost, Richard Wolf, and Teleflex. Companies in the Percutaneous Nephrolithotomy Market are strengthening their presence through several strategic approaches. They are investing heavily in research and development to enhance device efficiency, miniaturization, and imaging capabilities. Firms are entering partnerships and collaborations to expand geographic reach and diversify product offerings. Strategic acquisitions allow companies to consolidate market share and acquire innovative technologies. Focused entry into emerging markets captures new growth opportunities. Emphasis on advanced digital and minimally invasive solutions enhances competitive positioning.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional trends
    • 2.2.2 Product type trends
    • 2.2.3 Procedure type trends
    • 2.2.4 Patient trends
    • 2.2.5 End use trends
  • 2.3 CXO perspectives: Strategic imperatives
    • 2.3.1 Key decision points for industry executives
    • 2.3.2 Critical success factors for market players
  • 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising prevalence of kidney stone disease
      • 3.2.1.2 Increasing adoption of minimally invasive urological procedures
      • 3.2.1.3 Advancements in PCNL instrumentation and laser technologies
      • 3.2.1.4 Growing preference for mini-PCNL and micro-PCNL techniques
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of PCNL equipment and procedures
      • 3.2.2.2 Risk of surgical complications and postoperative infections
    • 3.2.3 Market opportunities
      • 3.2.3.1 Growing adoption of single-use PCNL instruments
      • 3.2.3.2 Expansion in emerging markets
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
  • 3.5 Technology landscape
    • 3.5.1 Current technological trends
    • 3.5.2 Emerging technologies
  • 3.6 Reimbursement scenario
  • 3.7 Future market trends
  • 3.8 Value chain analysis
  • 3.9 Porter's analysis
  • 3.10 PESTEL analysis
  • 3.11 Gap analysis
  • 3.12 Start-up scenario
  • 3.13 Consumer behaviour insights

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
    • 4.3.1 Global
    • 4.3.2 North America
    • 4.3.3 Europe
    • 4.3.4 Asia Pacific
  • 4.4 Competitive positioning matrix
  • 4.5 Competitive analysis of major market players
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New product launches
    • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Nephroscopes
    • 5.2.1 Rigid
    • 5.2.2 Flexible
  • 5.3 Lithotripsy systems
  • 5.4 Access systems
  • 5.5 Other product types

Chapter 6 Market Estimates and Forecast, By Procedure Type, 2021 - 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Standard PCNL
  • 6.3 Mini-PCNL
  • 6.4 Micro-PCNL

Chapter 7 Market Estimates and Forecast, By Patient, 2021 - 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Adult
  • 7.3 Pediatric

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Ambulatory surgery centers
  • 8.4 Other end use

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 ADVIN
  • 10.2 B. BRAUN
  • 10.3 Becton, Dickinson and Company
  • 10.4 Boston Scientific
  • 10.5 Coloplast
  • 10.6 COOK MEDICAL
  • 10.7 Dornier MedTech
  • 10.8 ELMED
  • 10.9 EMS ELECTRO MEDICAL SYSTEMS
  • 10.10 KARL STORZ
  • 10.11 OLYMPUS
  • 10.12 PolyDiagnost
  • 10.13 Richard Wolf
  • 10.14 Teleflex